HeraAI Singapore: Revolutionizing Medical Diagnostics with AI-Powered Early Detection

Date: February 28, 2026

In Singapore's thriving AI ecosystem, a new startup is making waves in an area that touches every single one of us: healthcare. HeraAI, founded in early 2025 by a team of Singaporean doctors and AI researchers, is pioneering AI-powered medical diagnostics that can detect diseases years before traditional methods ever could.

The inspiration for HeraAI came from a simple but troubling observation: many serious diseases—when caught early—are highly treatable, but the window of opportunity is often missed because current diagnostic methods either miss subtle early signs or require expensive, invasive procedures. "We asked ourselves," explains Dr. Sarah Chen, HeraAI's co-founder and former oncologist at Singapore General Hospital, "what if we could give every doctor an AI assistant that has seen millions of cases and can spot patterns the human eye might miss?"

How HeraAI Works

At its core, HeraAI developed a proprietary deep learning platform that analyzes standard medical data—blood test results, imaging scans, patient histories, and even voice patterns from telehealth consultations. The system doesn't replace doctors; instead, it acts as a powerful second opinion that runs continuously in the background, flagging potential concerns for human review.

The platform currently focuses on three high-impact areas: cancer screening, cardiovascular risk prediction, and diabetes complications. In cancer screening alone, HeraAI claims its system can detect early-stage indicators in standard blood work with 94% accuracy—potentially catching cancers that would otherwise go unnoticed until symptoms appear.

Partnerships with Singapore's Healthcare System

What sets HeraAI apart from other health tech startups is its deep integration with Singapore's public healthcare infrastructure. The company has partnered with the National Healthcare Group (NHG) and SingHealth to pilot its diagnostic tools across several polyclinics and community health centers.

Dr. Amirul Rahman, Director of Digital Health at NHG, has been closely involved with the pilot program. "The early results have been encouraging," he notes. "In the first three months of deployment, our doctors using HeraAI identified 47 patients with pre-diabetic complications who would have been missed using standard screening protocols. That's 47 people who now have a chance to change their lifestyle before full diabetes sets in."

Privacy and Trust

Handling sensitive medical data requires extraordinary care, and HeraAI has made data privacy a cornerstone of its operations. All patient data is processed locally within Singapore's borders, and the company has achieved MOH (Ministry of Health) certification for healthcare AI systems. Critically, the AI only provides recommendations—actual diagnoses and treatment decisions always remain with qualified medical professionals.

"We designed HeraAI to be transparent about its limitations," explains the company's CTO, Dr. James Liu. "Every recommendation includes a confidence score and an explanation of what factors contributed to that assessment. Doctors can see exactly why the AI flagged something, which helps build trust rather than creating a black box that medical professionals simply accept or reject without understanding."

Regional Expansion and Future Plans

Having proven its value in Singapore, HeraAI is now setting its sights on the wider Southeast Asian market. The company has secured Series A funding of $12 million led by Sequoia India, with participation from Singapore's Temasek Holdings. The funding will be used to expand into Indonesia, Thailand, and Vietnam, where AI-powered diagnostics could help address critical shortages of specialist medical expertise.

The startup is also expanding its diagnostic capabilities. By late 2026, HeraAI plans to add kidney disease prediction, mental health screening, and geriatric care optimization to its platform. The company is also exploring partnerships with insurance providers to create AI-enhanced health assessment products.

A Model for AI in Healthcare

HeraAI represents a compelling model for how AI can augment healthcare without replacing human judgment. By focusing on early detection—where intervention is most effective—and by working within existing healthcare systems rather than trying to disrupt them, this Singapore startup offers a pragmatic path forward for medical AI.

As Singapore continues to position itself as a global hub for AI innovation, HeraAI demonstrates that the technology's most profound impacts may not be in flashy consumer gadgets or industrial automation, but in the quiet, life-saving work of helping doctors catch diseases early enough to make a real difference.

This article is part of AI Dominance SG's ongoing coverage of Singapore's AI ecosystem. For more AI news from the Lion City, visit our archive.

Related Links: